{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:42Z","timestamp":1787026662941,"version":"build-2736575974"},"reference-count":249,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Rheumatoid arthritis (RA) involves a breakdown of immune tolerance to citrullinated proteins, leading to chronic inflammation and joint damage. Despite advances in treatment, achieving long-term remission remains a major challenge. Restoring immune tolerance to citrullinated proteins represents a promising strategy to halt disease progression and establish lasting remission. This review examines the potential of using citrullinated proteins or peptides to reestablish immune tolerance in RA. It explores the potential role of anti-citrullinated protein antibodies (ACPAs) in disease pathology and how utilizing or targeting specific citrullinated antigens could modulate immune responses. The review also highlights the therapeutic relevance of altering T and B cell function to regulate immune state. We explore mechanisms through which tolerance can be induced, including the use of citrullinated peptides to promote regulatory T (Treg) cell expansion and alter pathogenic B cell subsets. Emerging strategies aimed at re-educating the immune system are discussed, focusing on their potential to provide effective and durable treatment outcomes. These tolerance-based approaches are evaluated for their capacity to shift the immune response away from autoimmunity and towards sustained remission.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1648913","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:25:34Z","timestamp":1764051934000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Citrullinated peptides as drug candidates for rheumatoid arthritis"],"prefix":"10.3389","volume":"16","author":[{"given":"Adrian H.","family":"Bustos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Br\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tue Wenzel","family":"Kragstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Astakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"B1","unstructured":"Rheumatoid arthritis\n          \n          2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/FPUBH.2024.1478376\/BIBTEX","article-title":"Health-related quality of life profiles in patients with rheumatoid arthritis: a latent profile analysis","volume":"12","author":"Song","year":"2024","journal-title":"Front Public Heal"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S41927-019-0080-9\/TABLES\/5","article-title":"Health-related quality of life in patients with rheumatoid arthritis","volume":"3","author":"Katchamart","year":"2019","journal-title":"BMC Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/ARD.2005.040998","article-title":"Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation","volume":"65","author":"Alenius","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ART.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/RHEUMATOLOGY\/41.7.809","article-title":"Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors","volume":"41","author":"Bas","year":"2002","journal-title":"Rheumatology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/S13075-023-03007-9","article-title":"Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis","volume":"25","author":"Umemoto","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-024-03470-Y","article-title":"The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis","volume":"27","author":"Floris","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.24875\/RIC.24000181","article-title":"Evaluation of anti-citrullinated and anti-carbamylated antibodies in mexicans with rheumatoid arthritis and at-risk individuals","volume":"76","author":"Lara-Ram\u00edrez","year":"2024","journal-title":"Rev Investig Cl\u00ednica"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00380-0","article-title":"Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study","volume":"5","author":"Kronzer","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1002\/ART.27638","article-title":"The number of elevated cytokines\/chemokines in pre-clinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner","volume":"62","author":"Deane","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ART.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ART.27584","article-title":"2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11926-025-01180-1\/FIGURES\/1","article-title":"T cell dysregulation in rheumatoid arthritis: from genetic susceptibility to established disease","volume":"27","author":"Chin","year":"2025","journal-title":"Curr Rheumatol Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI185217","article-title":"Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis","volume":"135","author":"Inamo","year":"2025","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni0407-345","article-title":"TH-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.132233","article-title":"IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes","volume":"70","author":"Hot","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/BERH.2001.0187","article-title":"The balance of Th1\/Th2 cytokines in rheumatoid arthritis","volume":"15","author":"Schulze-Koops","year":"2001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/RMDOPEN-2022-002563","article-title":"Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium","volume":"8","author":"Murray-Brown","year":"2022","journal-title":"RMD Open"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-49186-0","article-title":"Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium","volume":"15","author":"Dunlap","year":"2024","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ART.11487;JOURNAL:JOURNAL:15290131;REQUESTEDJOURNAL:JOURNAL:15290131;WGROUP:STRING:PUBLICATION","article-title":"Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction","volume":"50","author":"Zwerina","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ART.38941;PAGE:STRING:ARTICLE\/CHAPTER","article-title":"CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity","volume":"67","author":"Carvalheiro","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-35264-8","article-title":"Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis","volume":"14","author":"Moon","year":"2023","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/AR3736","article-title":"Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis","volume":"14","author":"Carter","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/AJT.15546\/ATTACHMENT\/DA3E9522-5899-4306-B2C1-08F8F3B2279F\/MMC8-SUP8-LEGENDS.PDF","article-title":"Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs","volume":"20","author":"Mohib","year":"2020","journal-title":"Am J Transplant"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230101","article-title":"Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice","volume":"220","author":"Aoun","year":"2023","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/J.IMMUNI.2013.11.017","article-title":"Tuning of antigen sensitivity by TCRT cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues","volume":"40","author":"Honda","year":"2014","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.181.7.4832","article-title":"NFATc1 regulates PD-1 expression upon T cell activation","volume":"181","author":"Oestreich","year":"2008","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/JOURNAL.PPAT.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-02021-6","article-title":"PD-1 and CD73 on naive CD4+ T cells synergistically limit responses to self","volume":"26","author":"Nettersheim","year":"2024","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0192704","DOI":"10.1371\/JOURNAL.PONE.0192704","article-title":"Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression","volume":"13","author":"Guo","year":"2018","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-015-0859-Z\/FIGURES\/6","article-title":"Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways","volume":"17","author":"Liu","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/S10753-013-9718-8\/FIGURES\/3","article-title":"Expression of programmed death-1 PD-1. on CD4+ and CD8+ T cells in rheumatoid arthritis","volume":"37","author":"Li","year":"2014","journal-title":"Inflammation"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2017-211216","article-title":"Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment","volume":"76","author":"Belkhir","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e3001199","DOI":"10.1371\/JOURNAL.PBIO.3001199","article-title":"PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype","volume":"19","author":"Fanelli","year":"2021","journal-title":"PloS Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/584303","article-title":"Induction of th17 lymphocytes and treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"2013","author":"Estrada-Capetillo","year":"2013","journal-title":"J Immunol Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/RHEUMATOLOGY\/KEQ338","article-title":"Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival","volume":"50","author":"Moura","year":"2011","journal-title":"Rheumatology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-00582-4","article-title":"BAFF, involved in B cell activation through the NF-\u03baB pathway, is related to disease activity and bone destruction in rheumatoid arthritis","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/J.IMMUNI.2008.06.009\/ATTACHMENT\/9130E48E-1041-4BF7-8090-92D63BB82F16\/MMC1.PDF","article-title":"T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells","volume":"29","author":"Herlands","year":"2008","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1769","article-title":"BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-\u03baB pathway","volume":"3","author":"Pone","year":"2012","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/J.INTIMP.2020.106933","article-title":"Nanoparticle-facilitated delivery of BAFF-R siRNA for B cell intervention and rheumatoid arthritis therapy","volume":"88","author":"Wu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/ARD.2011.153312","article-title":"Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis","volume":"70","author":"Yeo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/J.HUMIMM.2010.01.010","article-title":"IL-21 regulates Th17 cells in rheumatoid arthritis","volume":"71","author":"Niu","year":"2010","journal-title":"Hum Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS9040915","article-title":"Neutrophil extracellular traps NETs. Take the central stage in driving autoimmune responses","volume":"9","author":"Fousert","year":"2020","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JAUT.2017.10.008","article-title":"NETtling\u201d the host: Breaking of tolerance in chronic inflammation and chronic infection","volume":"88","author":"Skopelja-Gardner","year":"2018","journal-title":"J Autoimmun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLMED.2018.12.008","article-title":"Neutrophils in rheumatoid arthritis: breaking immune tolerance and fueling disease","volume":"25","author":"O\u2019Neil","year":"2019","journal-title":"Trends Mol Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/ART.40401","article-title":"Antibody responses to citrullinated and noncitrullinated antigens in the sputum of subjects with rheumatoid arthritis and subjects at risk for development of rheumatoid arthritis","volume":"70","author":"Demoruelle","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ART.40066","article-title":"Anti\u2013citrullinated protein antibodies are associated with neutrophil extracellular traps in the sputum in relatives of rheumatoid arthritis patients","volume":"69","author":"Demoruelle","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2013-204912\/ATTACHMENT\/4B04654F-910E-47A2-871A-8A084A62E899\/MMC3.PDF","article-title":"Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: Identification and validation","volume":"74","author":"Ytterberg","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ART.38066","article-title":"Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease","volume":"65","author":"Willis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/ARD.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/PATH.4359","article-title":"Neutrophil extracellular traps promote differentiation and function of fibroblasts","volume":"233","author":"Chrysanthopoulou","year":"2014","journal-title":"J Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1189\/JLB.3AB0815-379RR","article-title":"Nicotine induces neutrophil extracellular traps","volume":"100","author":"Hosseinzadeh","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2022.103102","article-title":"Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered","volume":"21","author":"Gremese","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01154-0","article-title":"Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis","volume":"20","author":"Holers","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2016.01296\/PDF","article-title":"How rheumatoid arthritis can result from provocation of the immune system by microorganisms and viruses","volume":"7","author":"Arleevskaya","year":"2016","journal-title":"Front Microbiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2004.02.002","article-title":"Epstein\u2013Barr virus and rheumatoid arthritis","volume":"3","author":"Balandraud","year":"2004","journal-title":"Autoimmun Rev"},{"key":"B61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/S40168-016-0206-X\/FIGURES\/4","article-title":"The lung microbiota in early rheumatoid arthritis and autoimmunity","volume":"4","author":"Scher","year":"2016","journal-title":"Microbiome"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2013","author":"Scher","year":"2013","journal-title":"Elife"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn4722","article-title":"Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes","volume":"15","author":"Thompson","year":"2023","journal-title":"Sci Transl Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2024.1465889\/XML","article-title":"Mechanisms governing bystander activation of T cells","volume":"15","author":"Yosri","year":"2024","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/J.JTAUTO.2020.100048","article-title":"Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis","volume":"3","author":"Bo","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/ART.39321","article-title":"Promotion of inflammatory arthritis by interferon regulatory factor 5 in a mouse model","volume":"67","author":"Duffau","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/ART.39491","article-title":"Antibodies to porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology","volume":"68","author":"Kharlamova","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.139","article-title":"Periodontitis in RA\u2014the citrullinated enolase connection","volume":"6","author":"Lundberg","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.7.3248-3256.1999","article-title":"Purification, characterization, and sequence analysis of a potential virulence factor from porphyromonas gingivalis, peptidylarginine deiminase","volume":"67","author":"McGraw","year":"1999","journal-title":"Infect Immun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/ART.42370","article-title":"Association of antibodies to prevotella copri in anti-cyclic citrullinated peptide-positive individuals at risk of developing rheumatoid arthritis and in patients with early or established rheumatoid arthritis","volume":"75","author":"Seifert","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/RHEUMATOLOGY\/KEAA792","article-title":"Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis","volume":"60","author":"Rooney","year":"2021","journal-title":"Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/ART.42616","article-title":"Alteration of gut microbiota in individuals at high-risk for rheumatoid arthritis associated with disturbed metabolome and the initiation of arthritis through the triggering of mucosal immunity imbalance","volume":"75","author":"Luo","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/ART.40003\/ABSTRACT","article-title":"Evidence of the immune relevance of prevotella copri, a gut microbe, in patients with rheumatoid arthritis","volume":"69","author":"Pianta","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.932393\/BIBTEX","article-title":"Cytokine competent gut-joint migratory T Cells contribute to inflammation in the joint","volume":"13","author":"Lefferts","year":"2022","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/ART.39771\/ABSTRACT","article-title":"Elevated igA plasmablast levels in subjects at risk of developing rheumatoid arthritis","volume":"68","author":"Kinslow","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/ART.40587\/ABSTRACT","article-title":"Affinity maturation drives epitope spreading and generation of proinflammatory anti\u2013citrullinated protein antibodies in rheumatoid arthritis","volume":"70","author":"Elliott","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/CEI.13591","article-title":"Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients","volume":"204","author":"Roos Ljungberg","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn5166","article-title":"Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum","volume":"14","author":"Chriswell","year":"2022","journal-title":"Sci Transl Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/ACI.0000000000000966","article-title":"Association between silicosis and autoimmune disease","volume":"24","author":"Fireman","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2016.00097\/BIBTEX","article-title":"Silica, silicosis, and autoimmunity","volume":"7","author":"Pollard","year":"2016","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0195550","DOI":"10.1371\/JOURNAL.PONE.0195550","article-title":"Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study","volume":"13","author":"Choi","year":"2018","journal-title":"PloS One"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/ART.40760\/ABSTRACT","article-title":"Affinity maturation of the anti\u2013citrullinated protein antibody paratope drives epitope spreading and polyreactivity in rheumatoid arthritis","volume":"71","author":"Kongpachith","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"7592851","DOI":"10.1155\/2019\/7592851","article-title":"An overview of the intrinsic role of citrullination in autoimmune disorders","volume":"2019","author":"Alghamdi","year":"2019","journal-title":"J Immunol Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM14040400","article-title":"The role of citrullination modification in CD4+ T cells in the pathogenesis of immune-related diseases","volume":"14","author":"Chen","year":"2024","journal-title":"Biomolecules"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20110640","article-title":"Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells","volume":"208","author":"Ireland","year":"2011","journal-title":"J Exp Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.129687","article-title":"Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination","volume":"4","author":"Sun","year":"2019","journal-title":"JCI Insight"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2008-04-149039","article-title":"Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation","volume":"112","author":"Loos","year":"2008","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ART.38637","article-title":"Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy","volume":"66","author":"James","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/S10067-022-06315-8","article-title":"Imbalance of Th17, Treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritis","volume":"41","author":"Wang","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.572858\/BIBTEX","article-title":"Th17\/treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis","volume":"11","author":"Paradowska-Gorycka","year":"2020","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/JCMM.12353","article-title":"Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis","volume":"18","author":"Dong","year":"2014","journal-title":"J Cell Mol Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25246-7","article-title":"Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis","volume":"12","author":"Wu","year":"2021","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/SJI.12792","article-title":"CD21-\/low B cells associate with joint damage in rheumatoid arthritis patients","volume":"90","author":"Thorarinsdottir","year":"2019","journal-title":"Scand J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS10030647","article-title":"ACPA status correlates with differential immune profile in patients with rheumatoid arthritis","volume":"10","author":"Floudas","year":"2021","journal-title":"Cells"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.139032","article-title":"Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint","volume":"5","author":"Floudas","year":"2020","journal-title":"JCI Insight"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/ART.42839","article-title":"Expansion of HLA-DR positive peripheral helper T and naive B cells in anticitrullinated protein antibody-positive individuals at risk for rheumatoid arthritis","volume":"76","author":"Takada","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/RHEUMATOLOGY\/KEAA186","article-title":"Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis","volume":"59","author":"Fortea-Gordo","year":"2020","journal-title":"Rheumatology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"209ra150","DOI":"10.1126\/scitranslmed.3006869","article-title":"Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis","volume":"5","author":"Romero","year":"2013","journal-title":"Sci Transl Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/J.CHEMBIOL.2018.03.002","article-title":"The rheumatoid arthritis-associated citrullinome","volume":"25","author":"Tilvawala","year":"2018","journal-title":"Cell Chem Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/S10067-016-3247-4\/FIGURES\/2","article-title":"Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF\/TOF","volume":"35","author":"Wang","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1074\/MCP.RA118.000696","article-title":"Mining the human tissue proteome for protein citrullination","volume":"17","author":"Lee","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"B104","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ART.37720","article-title":"The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and \u03b2-actin","volume":"65","author":"Van Beers","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1136\/ARD.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"Van Der Woude","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-016-1031-0\/FIGURES\/4","article-title":"Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis","volume":"18","author":"Johansson","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/AR4322\/TABLES\/2","article-title":"ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression","volume":"15","author":"Van Beers","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-022-02945-0\/FIGURES\/5","article-title":"Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage","volume":"24","author":"Li","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.93688","article-title":"Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage","volume":"2","author":"Ge","year":"2017","journal-title":"JCI Insight"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/ART.40698\/ABSTRACT","article-title":"Structural basis of cross-reactivity of anti\u2013citrullinated protein antibodies","volume":"71","author":"Ge","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ART.40699\/ABSTRACT","article-title":"Recognition of amino acid motifs, rather than specific proteins, by human plasma cell\u2013derived monoclonal antibodies to posttranslationally modified proteins in rheumatoid arthritis","volume":"71","author":"Steen","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2019-216499","article-title":"Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications","volume":"79","author":"Kissel","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/ART.41385\/ABSTRACT","article-title":"Different hierarchies of anti\u2013modified protein autoantibody reactivities in rheumatoid arthritis","volume":"72","author":"Sahlstr\u00f6m","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1074\/MCP.M116.062919","article-title":"Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans","volume":"16","author":"Hafkenscheid","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.201747446","article-title":"Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection","volume":"48","author":"Lloyd","year":"2018","journal-title":"Eur J Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2017-212052","article-title":"B-cell receptor sequencing of anti-citrullinated protein antibody ACPA. IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation","volume":"77","author":"Vergroesen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2014-206598","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","volume":"75","author":"Rombouts","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/RHEUMATOLOGY\/KEAD282","article-title":"CCCTC-binding factor: the specific transcription factor of \u03b2-galactoside \u03b1-2,6-sialyltransferase 1 that upregulates the sialylation of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"63","author":"Zhao","year":"2024","journal-title":"Rheumatology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11205","article-title":"Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis","volume":"7","author":"Ohmi","year":"2016","journal-title":"Nat Commun"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/J.JMB.2014.07.006","article-title":"Structural characterization of anti-inflammatory immunoglobulin G fc proteins","volume":"426","author":"Ahmed","year":"2014","journal-title":"J Mol Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1307864110\/-\/DCSUPPLEMENTAL","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/ART.42320","article-title":"Combination of two monoclonal anti\u2013citrullinated protein antibodies induced tenosynovitis, pain, and bone loss in mice in a peptidyl arginine deiminase-4-dependent manner","volume":"75","author":"Krishnamurthy","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2018-214967","article-title":"Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts","volume":"78","author":"Sun","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.1800346","article-title":"Characterization of a synovial B cell\u2013derived recombinant monoclonal antibody targeting stromal calreticulin in the rheumatoid joints","volume":"201","author":"Corsiero","year":"2018","journal-title":"J Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/JBMR.3158","article-title":"Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin","volume":"32","author":"Engdahl","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/ART.42679","article-title":"Anti-citrullinated protein antibodies with multiple specificities ameliorate collagen antibody-induced arthritis in a time-dependent manner","volume":"76","author":"Gomez","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-012-9841-6\/FIGURES\/6","article-title":"Anti-citrullinated protein antibodies activated ERK1\/2 and JNK mitogen-activated protein kinases via binding to surface-expressed citrullinated GRP78 on mononuclear cells","volume":"33","author":"Lu","year":"2013","journal-title":"J Clin Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/ART.27386","article-title":"Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte\/macrophages and stimulate tumor necrosis factor \u03b1 production","volume":"62","author":"Lu","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B130","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/CEI.13527","article-title":"Increased expression of CXCL2 in ACPA-positive rheumatoid arthritis and its role in osteoclastogenesis","volume":"203","author":"Wang","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ART.30081","article-title":"Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-016-1128-5\/FIGURES\/5","article-title":"A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease","volume":"18","author":"Hatterer","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.1402334","article-title":"IgM and igA rheumatoid factors purified from rheumatoid arthritis sera boost the fc receptor\u2013 and complement-dependent effector functions of the disease-specific anti\u2013citrullinated protein autoantibodies","volume":"194","author":"Anquetil","year":"2015","journal-title":"J Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0201-9","article-title":"ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome","volume":"17","author":"Dong","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/ART.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor \u03b1 through Fc\u03b3 receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7637","article-title":"Immune complexes regulate bone metabolism through FcR\u03b3 signalling","volume":"6","author":"Negishi-Koga","year":"2015","journal-title":"Nat Commun"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1301001110\/SUPPL_FILE\/PNAS.201301001SI.PDF","article-title":"Inflammatory monocytes and Fc\u03b3 receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice","volume":"110","author":"Seeling","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.651049\/BIBTEX","article-title":"IgA immune complexes induce osteoclast-mediated bone resorption","volume":"12","author":"Breedveld","year":"2021","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e2304199121","DOI":"10.1073\/PNAS.2304199121\/SUPPL_FILE\/PNAS.2304199121.SD06.XLSX","article-title":"The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis","volume":"121","author":"Thomas","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B140","doi-asserted-by":"publisher","first-page":"102297","DOI":"10.1016\/J.JAUT.2019.06.008","article-title":"Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis","volume":"105","author":"El Shikh","year":"2019","journal-title":"J Autoimmun"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-023-34469-1","article-title":"Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4","volume":"13","author":"Yoshida","year":"2023","journal-title":"Sci Rep"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM13040630\/S1","article-title":"Anti-citrullinated protein antibody reactivity towards neutrophil-derived antigens: clonal diversity and inter-individual variation","volume":"13","author":"C\u00eerciumaru","year":"2023","journal-title":"Biomolecules"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2018.03033\/BIBTEX","article-title":"Differential ACPA binding to nuclear antigens reveals a PAD-independent pathway and a distinct subset of acetylation cross-reactive autoantibodies in rheumatoid arthritis","volume":"9","author":"Lloyd","year":"2019","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1046\/J.1365-2567.1997.00249.X","article-title":"Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc\u03b3RI CD64.: role of immune complexes and cytokines in induction of receptor expression","volume":"91","author":"Quayle","year":"1997","journal-title":"Immunology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1136\/ARD.53.8.515","article-title":"Role of Fc gamma receptors in the activation of neutrophils by soluble and insoluble immunoglobulin aggregates isolated from the synovial fluid of patients with rheumatoid arthritis","volume":"53","author":"Robinson","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"B146","article-title":"Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for Fc\u03b3RI in the pathogenesis of synovial inflammation","volume":"36","author":"Kempers","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"eaag3358","DOI":"10.1126\/sciimmunol.aag3358","article-title":"Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis","volume":"2","author":"Carmona-Rivera","year":"2017","journal-title":"Sci Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAUT.2019.01.003","article-title":"Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37","volume":"98","author":"Ribon","year":"2019","journal-title":"J Autoimmun"},{"key":"B150","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/J.JAUT.2017.01.006","article-title":"Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation","volume":"80","author":"Bawadekar","year":"2017","journal-title":"J Autoimmun"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J Exp Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nri.2016.124","article-title":"The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting","volume":"17","author":"Malmstr\u00f6m","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2013-203947","article-title":"Environmental and genetic factors in the development of anticitrullinated protein antibodies ACPAs. and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins","volume":"74","author":"Hensvold","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/ART.40852\/ABSTRACT","article-title":"Complex relationships of smoking, HLA\u2013DRB1 genes, and serologic profiles in patients with early rheumatoid arthritis: update from a swedish population-based case\u2013control study","volume":"71","author":"Hedstr\u00f6m","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e64108","DOI":"10.1371\/JOURNAL.PONE.0064108","article-title":"HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody ACPA. Positive rheumatoid arthritis","volume":"8","author":"Balandraud","year":"2013","journal-title":"PloS One"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1178546\/BIBTEX","article-title":"Association of Human Leukocyte Antigen HLA. class II DRB1 and DQB1. alleles and haplotypes with Rheumatoid Arthritis in Sudanese patients","volume":"14","author":"Ali","year":"2023","journal-title":"Front Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1136\/ARD.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.202249889","article-title":"PAD2 immunization induces ACPA in wild-type and HLA-DR4 humanized mice","volume":"52","author":"Hemon","year":"2022","journal-title":"Eur J Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1713112114\/SUPPL_FILE\/PNAS.201713112SI.PDF","article-title":"Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types","volume":"114","author":"Arnoux","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ARD-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B161","doi-asserted-by":"publisher","first-page":"e70066","DOI":"10.1111\/1756-185X.70066","article-title":"Chinese registry of rheumatoid arthritis CREDIT. VI: temporal trends in patients with early rheumatoid arthritis and moderate-to-severe disease activity - A multicenter cohort study of treatment strategies and outcomes","volume":"28","author":"Deng","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/J.JOS.2023.03.020","article-title":"Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan NICER-J","volume":"29","author":"Suzuki","year":"2024","journal-title":"J Orthop Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/77i56a","article-title":"Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis the MITRA study. A cohort study of the Italian Society for Rheumatology","volume":"40","author":"Fornaro","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2015-208324","article-title":"Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point","volume":"75","author":"Aletaha","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/J.SEMARTHRIT.2023.152314","article-title":"Persistence of Janus-kinase JAK. inhibitors in rheumatoid arthritis: Australia wide study","volume":"64","author":"Scheepers","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/J.SEMARTHRIT.2017.08.007","article-title":"Persistence of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: An analysis of the South Korean National Health Insurance Database","volume":"47","author":"Lee","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/S00393-023-01323-8\/FIGURES\/5","article-title":"Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany\u2014a health insurance claims data analysis","volume":"82","author":"Fiehn","year":"2023","journal-title":"Z Rheumatol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1136\/ARD-2023-224670\/ATTACHMENT\/E1FA2A52-EA05-4377-AAA6-E34AE045233A\/MMC1.PDF","article-title":"Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers the \u2018JAK-pot\u2019 study","volume":"83","author":"Aymon","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1136\/RMDOPEN-2018-000742","article-title":"Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib","volume":"5","author":"Bird","year":"2019","journal-title":"RMD Open"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1136\/ARD.2010.148759","article-title":"Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries","volume":"70","author":"Chatzidionysiou","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/ART.30233","article-title":"B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study","volume":"63","author":"Sellam","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2015-207942","article-title":"Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial","volume":"75","author":"Sokolove","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAUT.2024.103320","article-title":"Autoreactive B cells remain active despite clinical disease control in rheumatoid arthritis","volume":"149","author":"Neppelenbroek","year":"2024","journal-title":"J Autoimmun"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1136\/RMDOPEN-2021-001662","article-title":"Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL","volume":"7","author":"Chatzidionysiou","year":"2021","journal-title":"RMD Open"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.1900191","article-title":"Measuring thymic clonal deletion at the population level","volume":"202","author":"Breed","year":"2019","journal-title":"J Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12820-3","article-title":"Dormant pathogenic CD4+ T cells are prevalent in the peripheral repertoire of healthy mice","volume":"10","author":"Cebula","year":"2019","journal-title":"Nat Commun"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3331","article-title":"CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors","volume":"17","author":"Kalekar","year":"2016","journal-title":"Nat Immunol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20182002","article-title":"T cell anergy in perinatal mice is promoted by T reg cells and prevented by IL-33","volume":"216","author":"Tuncel","year":"2019","journal-title":"J Exp Med"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/SJ.ICB.7100161","article-title":"Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells","volume":"86","author":"Parish","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"e2315419121","DOI":"10.1073\/PNAS.2315419121\/SUPPL_FILE\/PNAS.2315419121.SAPP.PDF","article-title":"Extraislet expression of islet antigen boosts T cell exhaustion to partially prevent autoimmune diabetes","volume":"121","author":"Selck","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.2300785\/1655607\/JI2300785.PDF","article-title":"Altering \u03b2 Cell antigen exposure to exhausted CD8+ T cells prevents autoimmune diabetes in mice","volume":"212","author":"De George","year":"2024","journal-title":"J Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.174.4.2046","article-title":"Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo","volume":"174","author":"Redmond","year":"2005","journal-title":"J Immunol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1093\/INTIMM\/DXT031","article-title":"DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8+ T cells independently of PD-1 and PD-L1","volume":"25","author":"Mukherjee","year":"2013","journal-title":"Int Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1146\/ANNUREV-IMMUNOL-042718-041717\/CITE\/REFWORKS","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.2337\/DB20-1170","article-title":"Tolerogenic delivery of a hybrid insulin peptide markedly prolongs islet graft survival in the NOD mouse","volume":"71","author":"Jamison","year":"2022","journal-title":"Diabetes"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.181.10.6923","article-title":"CD8+CD205+ Splenic dendritic cells are specialized to induce foxp3+ Regulatory T cells","volume":"181","author":"Yamazaki","year":"2008","journal-title":"J Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAUT.2019.04.016","article-title":"Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells","volume":"101","author":"Lorenzetti","year":"2019","journal-title":"J Autoimmun"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00200","article-title":"Effective B cell depletion with rituximab in the treatment of autoimmune diseases","volume":"206","author":"Kneitz","year":"2002","journal-title":"Immunobiology"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.V100.6.2257","article-title":"Rituximab treatment results in impaired secondary humoral immune responsiveness","volume":"100","author":"Van Der Kolk","year":"2002","journal-title":"Blood"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13596","article-title":"Infection risks of rituximab versus non-rituximab treatment for rheumatoid arthritis: A systematic review and meta-analysis","volume":"22","author":"Shi","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1002\/ART.22019","article-title":"Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis","volume":"54","author":"Roll","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2021.708168\/BIBTEX","article-title":"Real-life retention rates and reasons for switching of biological DMARDs in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"8","author":"Bhushan","year":"2021","journal-title":"Front Med"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41422-024-01068-2","article-title":"Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis","volume":"35","author":"Li","year":"2025","journal-title":"Cell Res"},{"key":"B195","doi-asserted-by":"publisher","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar6584","article-title":"A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity","volume":"11","author":"Karnell","year":"2019","journal-title":"Sci Transl Med"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1136\/RMDOPEN-2023-003317","article-title":"The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis","volume":"9","author":"Kivitz","year":"2023","journal-title":"RMD Open"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25084394\/S1","article-title":"The biologic IRL201805 alters immune tolerance leading to prolonged pharmacodynamics and efficacy in rheumatoid arthritis patients","volume":"25","author":"Hall","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/RHEUMATOLOGY\/KEW287","article-title":"Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I\/IIA RAGULA clinical trial in rheumatoid arthritis","volume":"55","author":"Kirkham","year":"2016","journal-title":"Rheumatology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.4172\/2167-0870.1000339","article-title":"Phase I clinical trial with a novel altered peptide ligand derived from human heat-shock protein 60 for treatment of rheumatoid arthritis: safety, pharmacokinetics and preliminary therapeutic effects","volume":"8","author":"Oramas","year":"2018","journal-title":"J Clin Trials"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1007\/S10067-018-4360-3\/FIGURES\/3","article-title":"CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis","volume":"38","author":"Corrales","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2010.550590","article-title":"An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis","volume":"44","author":"Dominguez","year":"2011","journal-title":"Autoimmunity"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1002\/ART.24916","article-title":"Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial","volume":"60","author":"Koffeman","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.160964","article-title":"Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide\/calcitriol liposomes in ACPA+ rheumatoid arthritis","volume":"7","author":"Sonigra","year":"2022","journal-title":"JCI Insight"},{"key":"B205","doi-asserted-by":"publisher","first-page":"e004727","DOI":"10.1136\/RMDOPEN-2024-004727","article-title":"Sustained drug-free remission in rheumatoid arthritis associated with diffuse large B-cell lymphoma following tandem CD20-CD19-directed non-cryopreserved CAR-T cell therapy using zamtocabtagene autoleucel","volume":"10","author":"Szabo","year":"2024","journal-title":"RMD Open"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1136\/ARD-2024-226437","article-title":"CD-19 CAR-T cells for polyrefractory rheumatoid arthritis","volume":"84","author":"Lidar","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1136\/ARD-2024-226017","article-title":"Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis","volume":"83","author":"Haghikia","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2020-217844","article-title":"In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells","volume":"80","author":"Zhang","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1298815\/BIBTEX","article-title":"Concurrent remission of lymphoma and Sj\u00f6gren\u2019s disease following anti-CD19 chimeric antigen receptor-T cell therapy for diffuse large B-cell lymphoma: a case report","volume":"14","author":"Sheng","year":"2023","journal-title":"Front Immunol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"e0131152","DOI":"10.1371\/JOURNAL.PONE.0131152","article-title":"Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis","volume":"10","author":"Ning","year":"2015","journal-title":"PloS One"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/J.INTIMP.2024.111764","article-title":"Tolerogenic dendritic cells alleviate collagen-induced arthritis by regulating T-cell differentiation and inhibiting NLRP3-mediated apoptosis","volume":"130","author":"Yuan","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.201445217","article-title":"Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members","volume":"45","author":"Dixon","year":"2015","journal-title":"Eur J Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1820039116\/SUPPL_FILE\/PNAS.1820039116.SAPP.PDF","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-858720.30104-2","article-title":"Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide\u2014for type 1 diabetes","volume":"8","author":"Nikolic","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.1054968\/BIBTEX","article-title":"Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients","volume":"13","author":"Nikolic","year":"2022","journal-title":"Front Immunol"},{"key":"B217","first-page":"946","article-title":"Phase 1 study of immunotherapy using autoantigen-loaded dendritic cells in patients with anti-citrullinated peptide antigen positive rheumatoid arthritis - ACR meeting abstracts","author":"Bin Joo","year":"2014","journal-title":"ACR\/AHRP Annu Meet"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B219","doi-asserted-by":"publisher","first-page":"e078231","DOI":"10.1136\/BMJOPEN-2023-078231","article-title":"Design of TOLERANT: phase I\/II safety assessment of intranodal administration of HSP70\/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis","volume":"14","author":"Stoppelenburg","year":"2024","journal-title":"BMJ Open"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2209856\/SUPPL_FILE\/NEJMOA2209856_DATA-SHARING.PDF","article-title":"A phase 2 trial of peresolimab for adults with rheumatoid arthritis","volume":"388","author":"Tuttle","year":"2023","journal-title":"N Engl J Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1056\/NEJME2300734\/SUPPL_FILE\/NEJME2300734_DISCLOSURES.PDF","article-title":"Reinforcing the checkpoint in rheumatoid arthritis","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1002\/ART.21654","article-title":"Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4\u2013producing regulatory T cells: A novel function for an ancient protein","volume":"54","author":"Brownlie","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.166.3.1492","article-title":"The human endoplasmic reticulum molecular chaperone biP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis","volume":"166","author":"Corrigall","year":"2001","journal-title":"J Immunol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf7779","article-title":"Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes","volume":"9","author":"Ali","year":"2017","journal-title":"Sci Transl Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2249.2008.03814.X","article-title":"Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study","volume":"155","author":"Thrower","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.2165\/11588120-000000000-00000\/FIGURES\/1","article-title":"Glatiramer acetate in the treatment of multiple sclerosis: Emerging concepts regarding its mechanism of action","volume":"25","author":"Lalive","year":"2011","journal-title":"CNS Drugs"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.811489","article-title":"The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment","volume":"9","author":"Messina","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1002\/ART.24027","article-title":"Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial","volume":"58","author":"Muller","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS-2012-202460","article-title":"Lupuzor\/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial","volume":"72","author":"Zimmer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.175.9.5839","article-title":"Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog","volume":"175","author":"Monneaux","year":"2005","journal-title":"J Immunol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314556138\/ASSET\/IMAGES\/LARGE\/10.1177_0961203314556138-FIG3.JPEG","article-title":"Resetting the autoreactive immune system with a therapeutic peptide in lupus","volume":"24","author":"Schall","year":"2015","journal-title":"Lupus"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.BIOCHEM.9B00802\/ASSET\/IMAGES\/LARGE\/BI9B00802_0003.JPEG","article-title":"The road ahead for the development of macrocyclic peptide ligands","volume":"59","author":"Passioura","year":"2020","journal-title":"Biochemistry"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160619","article-title":"Macrocycles as protein\u2013protein interaction inhibitors","volume":"474","author":"Dougherty","year":"2017","journal-title":"Biochem J"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES12122740\/S1","article-title":"Proteomic profile regulated by the immunomodulatory jusvinza drug in neutrophils isolated from rheumatoid arthritis patients","volume":"12","author":"Hern\u00e1ndez-Cede\u00f1o","year":"2024","journal-title":"Biomedicines"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.0400061101\/ASSET\/2E282928-4438-476F-A26D-27D6EE6EB463\/ASSETS\/GRAPHIC\/ZPQ0100441620004.JPEG","article-title":"Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis","volume":"101","author":"Prakken","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B236","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ni1240","article-title":"Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics","volume":"6","author":"Bromley","year":"2005","journal-title":"Nat Immunol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.174.3.1693","article-title":"A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis","volume":"174","author":"Burman","year":"2005","journal-title":"J Immunol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1805317","article-title":"Vitamin D: does it help Tregs in active rheumatoid arthritis patients","volume":"16","author":"Samy El-Banna","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.1402457","article-title":"Immune tolerance induction with multiepitope peptide derived from citrullinated autoantigens attenuates arthritis manifestations in adjuvant arthritis rats","volume":"194","author":"Gertel","year":"2015","journal-title":"J Immunol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.3390\/VACCINES9050448\/S1","article-title":"Vaccination by two DerG LEAPS conjugates incorporating distinct proteoglycan PG, aggrecan. epitopes provides therapy by different immune mechanisms in a mouse model of rheumatoid arthritis","volume":"9","author":"Zimmerman","year":"2021","journal-title":"Vaccines"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.2c00144","article-title":"Cyclic citrullinated peptide aptamer treatment attenuates collagen-induced arthritis","volume":"23","author":"Khatri","year":"2022","journal-title":"Biomacromolecules"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230209","article-title":"The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance","volume":"220","author":"McElwee","year":"2023","journal-title":"J Exp Med"},{"key":"B243","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-36257-x","article-title":"A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1136\/ARD-2022-223417","article-title":"Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies ACPA. in arthritis development","volume":"82","author":"Raposo","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0381-3","article-title":"Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases","volume":"18","author":"Chirivi","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1016\/J.VACCINE.2017.05.009","article-title":"An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis","volume":"35","author":"Mikecz","year":"2017","journal-title":"Vaccine"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1186\/S13075-015-0666-6","article-title":"Targeting of anti-citrullinated protein\/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens","volume":"17","author":"Fernandes-Cerqueira","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1021\/ACSCHEMBIO.8B00118","article-title":"Stabilized cyclic peptides as scavengers of autoantibodies: neutralization of anticitrullinated protein\/peptide antibodies in rheumatoid arthritis","volume":"13","author":"Gunasekera","year":"2018","journal-title":"ACS Chem Biol"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-9899.S6-006","article-title":"Anti-citrullinated protein antibodies as novel therapeutic drugs in rheumatoid arthritis","author":"Chirivi","year":"2013","journal-title":"J Clin Cell Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:25:38Z","timestamp":1764051938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":249,"alternative-id":["10.3389\/fimmu.2025.1648913"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1648913","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"article-number":"1648913"}}